SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J958. A total of 5 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,193,000 | -18.6% | 293 | +52.6% | 0.08% | -66.8% |
Q3 2019 | $2,694,000 | -23.4% | 192 | 0.0% | 0.25% | -22.8% |
Q2 2019 | $3,515,000 | +19.5% | 192 | +3.8% | 0.32% | +12.3% |
Q1 2019 | $2,942,000 | +82.7% | 185 | +62.3% | 0.28% | +79.2% |
Q3 2018 | $1,610,000 | +3.8% | 114 | -54.2% | 0.16% | -38.4% |
Q3 2017 | $1,551,000 | – | 249 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 32,000 | $3,065,000 | 0.03% |
IMC-Chicago, LLC | 14,000 | $1,341,000 | 0.00% |
SIMPLEX TRADING, LLC | 111 | $1,063,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 1,100 | $105,000 | 0.00% |